Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 14.8414.4512.358.4110.14

What is the latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS is 14.84 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202514.84
Mar202414.45
Mar202312.35
Mar20228.41
Mar202110.14

How is EV/Core EBITDA of SMS PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 14.84
2.70
Mar2024 14.45
17.00
Mar2023 12.35
46.85
Mar2022 8.41
-17.06
Mar2021 10.14 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹3,455.2 Cr 2.5% -11% 33.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,933.0 Cr -0.7% -3.6% 6% Stock Analytics
DIVIS LABORATORIES ₹175,833.0 Cr 1.1% -1.2% -0.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,549.0 Cr 1.6% 1.4% 36.7% Stock Analytics
CIPLA ₹113,155.0 Cr 0.7% 2.6% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,652.0 Cr -0.9% -2.5% 1.2% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

2.5%

-11%

33.8%

SENSEX

-0.7%

-3.6%

-9.1%


You may also like the below Video Courses